PsyPost
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Neuroscience
  • About
No Result
View All Result
Join
My Account
PsyPost
No Result
View All Result
Home Exclusive Psychopharmacology Cannabis

Meta-analysis fails to find evidence that medical marijuana influences quality of life

by Eric W. Dolan
April 10, 2017
Reading Time: 2 mins read
A marijuana bud. (Photo credit: Dank Depot)

A marijuana bud. (Photo credit: Dank Depot)

Share on TwitterShare on Facebook

New research indicates that marijuana has no impact on quality of life when used for many medical conditions. The findings appear in the peer-reviewed scientific journal Drug and Alcohol Dependence.

The researchers conducted a meta-analysis — a method of statistically examining previous research — of eleven scientific studies on cannabis or cannabinoids and quality of life. The meta-analysis failed to find a significant association between use of cannabis or cannabinoids and quality of life among those with medical conditions.

PsyPost interviewed one of the study’s authors, Itai Danovitch of Cedars-Sinai Medical Center in Los Angeles. Read his responses below:

PsyPost: Why were you interested in this topic?

Danovitch: Many cannabis users report that cannabis makes them feel better, that it improves their sense of wellbeing. One good scientific measure of wellbeing is “Quality of Life,” a person-centered indicator that measures perceptions about physical and mental health. We were interested to learn whether people using cannabis for medical conditions experienced significant changes in Quality of Life.

What should the average person take away from your study?

We did not find a clear association between cannabis use and Quality of Life. There were some indications of a positive association among studies that evaluated the effects of cannabis on pain, and other studies that failed to find any association. So, while cannabis may help alleviate symptoms of several medical conditions, at this point in time there is not convincing evidence that those effects lead to significant improvements in Quality of Life.

Are there any major caveats? What questions still need to be addressed?

Google News Preferences Add PsyPost to your preferred sources

Well, our study was a “meta-analysis,” which means it was a study of other studies. Only eleven studies met the standards we set, which limited our ability to make broad inferences about the effects of cannabis and Quality of Life. The studies had a great deal of variability, and since they were mostly designed to evaluate the effect of cannabis on medical conditions, it was difficult to disentangle whether changes in Quality of Life were attributable to those medical conditions, or to the cannabis itself. However, as more and more people are using cannabis on a regular basis to help with medical conditions, it is incumbent on us to understand the objective and subjective effects of cannabis over time.

Is there anything else you would like to add?

Cannabis is a complex herb that has many active constituents and exciting therapeutic potential. However, use of cannabis for medical indications is growing faster than the supporting evidence. And because cannabis can cause mild euphoria, it is difficult to separate its pleasurable effects from its therapeutic effects. It is important to scrutinize any medication, supplement or herb that is taken on a long-term basis for a health condition. And measuring Quality of Life is a particularly important way to evaluate the factors people care about most.

The study, “The impact of cannabis and cannabinoids for medical conditions on health-related quality of life: A systematic review and meta-analysis“, was also co-authored by Matthew Goldenberg, Mark William Reid, and Waguih William IsHak.

RELATED

Novel psychedelic compound 25C-NBF shows rapid antidepressant effects without addictive traits
Psychedelic Drugs

Novel psychedelic compound 25C-NBF shows rapid antidepressant effects without addictive traits

May 6, 2026
Psychedelic science breakthrough: Increased brain entropy from psilocybin predicts lasting psychological insight and well-being
Neuroimaging

Psychedelic science breakthrough: Increased brain entropy from psilocybin predicts lasting psychological insight and well-being

May 5, 2026
People with cannabis use disorder are more likely to be depressed, study finds
Cannabis

People with cannabis use disorder are more likely to be depressed, study finds

May 5, 2026
Democrats dislike Republicans more than Republicans dislike Democrats, studies find
Addiction

Combining alcohol with cocaine rewires the brain’s relapse pathways differently than cocaine alone

May 2, 2026
Ozempic and similar drugs may lower dementia risk for diabetes patients
Addiction

Weight-loss drug semaglutide reduces heavy alcohol drinking in new clinical trial

May 1, 2026
Gold digging is strongly linked to psychopathy and dark personality traits, study finds
Addiction

Mental health risks of cannabis addiction depend heavily on age

April 30, 2026
New psychology research reveals your face might determine how easily people remember your name
Addiction

A single dose of psilocybin outperforms nicotine patches for quitting smoking

April 27, 2026
New psychology research reveals your face might determine how easily people remember your name
Mental Health

Repeated doses of psilocybin show promise for treating obsessive-compulsive disorder

April 25, 2026

Follow PsyPost

The latest research, however you prefer to read it.

Daily newsletter

One email a day. The newest research, nothing else.

Google News

Get PsyPost stories in your Google News feed.

Add PsyPost to Google News
RSS feed

Use your favorite reader. We also syndicate to Apple News.

Copy RSS URL
Social media
Support independent science journalism

Ad-free reading, full archives, and weekly deep dives for members.

Become a member

Trending

  • The human brain appears to rely heavily on the thighs to accurately judge female body size
  • What your personality traits reveal about your sexual fantasies
  • Both men and women view a partner’s financial investment in a rival as a major relationship threat
  • Brain scans of 800 incarcerated men link psychopathy to an expanded cortical surface area
  • The gender friendship gap is driven primarily by white men, not a universal difference across groups

Science of Money

  • What traders actually look at: Eye-tracking study finds the price chart is largely ignored
  • When ICE ramps up, U.S.-born workers don’t fill the gap, study finds
  • Why a blue background can make a brown sofa look bigger
  • Why brand names like “Yum Yum” and “BonBon” taste sweeter to our brains
  • How the science of persuasion connects to B2B sales success

PsyPost is a psychology and neuroscience news website dedicated to reporting the latest research on human behavior, cognition, and society. (READ MORE...)

  • Mental Health
  • Neuroimaging
  • Personality Psychology
  • Social Psychology
  • Artificial Intelligence
  • Cognitive Science
  • Psychopharmacology
  • Contact us
  • Disclaimer
  • Privacy policy
  • Terms and conditions
  • Do not sell my personal information

(c) PsyPost Media Inc

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy

(c) PsyPost Media Inc